Peptide Labs presents pharmaceutical-grade Retatrutide powder, a novel triple hormone receptor agonist targeting GIP, GLP-1 and glucagon pathways. This research compound shows significant potential for metabolic disorder studies.
The white lyophilized powder maintains 99% purity as verified by HPLC analysis, making it ideal for laboratory investigations. Each batch undergoes rigorous quality control to ensure research reproducibility.
As a GIPR/GLP-1R agonist, Retatrutide demonstrates unique mechanisms of action in preclinical models. Researchers are investigating its potential applications in metabolic regulation and weight management studies.
Proper storage at 2-8°C in light-protected conditions maintains stability for up to 24 months. The peptide is provided in various research quantities to accommodate different experimental designs.
Current preclinical data suggests Retatrutide may influence multiple physiological pathways including: glucose metabolism modulation, appetite regulation mechanisms, and potential neuroprotective effects. However, all applications remain investigational at this stage.
This product is intended for research purposes only in controlled laboratory settings. Not for human consumption or diagnostic use. Researchers should handle all peptides using appropriate safety protocols.